Investor Overview

2018 was a strong year for our Tiara and Reducer product platforms. Both have achieved significant therapy development milestones, putting Neovasc on a stronger foundation from which to continue advancing these products commercially. We also have a clear value creation strategy for patients, employees, and investors. All of this is really good news for our outlook.

Read More >

Latest News

Neovasc Announces Changes to its Board of Directors

> read full release

Archive >

Programs and Events

Corporate Overview Presentation

Fred Colen, CEO, Neovasc, Inc.
from the Global Investment Conference
Monday, Sept. 9, 2019

.pdf format > .pptx format >

Corporate Overview Presentation

Fred Colen, Chief Executive Officer, Neovasc, Inc.
from the H.C. Wainwright 21st Annual
Global Investment Conference
Monday, Sept. 9, 2019

pdf >>
pptx >>

Financial Report Archives

2019 Financial Reports

News Release Archives

2019 News Releases

Share Information

Auditor
Grant Thornton LLP, Vancouver, BC

Legal Counsel
Blakes LLP, Vancouver, BC

Transfer Agent
Computershare, Vancouver, BC

Investor Relations
Chris Clark, Chief Financial Officer
investors@neovasc.com

To automatically receive news updates

register now